Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Go back to Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 29.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $29.85 | 52 Week Low | $28.25 | |||
| Day High | $29.85 | P/E | 18.09 | |||
| Day Low | $29.85 | EPS | $1.65 | |||
| Volume | 47,848 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $29.85 | 52 Week Low | $28.25 | |||
| Day High | $29.85 | P/E | 18.09 | |||
| Day Low | $29.85 | EPS | $1.65 | |||
| Volume | 47,848 | |||||



